NCT03457090

Brief Summary

To determine how venoarterial extracorporeal membrane oxygenation (ECMO) affects cerebral blood flow velocity (CBFV) measured by transcranial doppler (TCD), to determine whether specific changes in cerebral blood flow velocity may be associated with neurologic injury and to determine modifications of CBFV after withdrawal of ECMO.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 27, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 7, 2018

Completed
29 days until next milestone

Study Start

First participant enrolled

April 5, 2018

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
Last Updated

April 18, 2018

Status Verified

April 1, 2018

Enrollment Period

2.4 years

First QC Date

February 27, 2018

Last Update Submit

April 16, 2018

Conditions

Keywords

neurologic complication, transcranial Doppler ultrasound

Outcome Measures

Primary Outcomes (2)

  • Cerebral blood flow velocities evolution

    Cerebral blood flow velocities evolution over the time

    24 hours

  • The correlation of Cerebral blood flow velocities with the variation of the cardiac output and ECMO flow.

    The correlation with the variation of the cardiac output and ECMO flow.

    24 hours

Secondary Outcomes (3)

  • Relation between acute neurologic injury and variation of CBFV

    24 hours

  • Modification of the CBFV detected by TCD after the withdrawal of the ECMO.

    24 hours

  • Relation between the CBFV, the NIRS, the cardiac flow and the ECMO flow.

    24 hours

Study Arms (1)

Patient treated with ECMO

EXPERIMENTAL

Patient treated with ECMO will have Examination : a TCD and Trans-Thoracic Echocardiography (TTE)

Other: Examination : a TCD and Trans-Thoracic Echocardiography

Interventions

Examination that involves the completion of a TCD and an TTE (Trans-Thoracic Echocardiography) : * To reports clinical parameters at the time of the examination : ECG data: sinus rhythm, atrial or ventricular arrhythmia, state of consciousness, heart rate, O2 saturation * To review of pharmacological parameters at the time of the examination : presence of sedation; presence, type and dose of catecholamines. * To collect biological data from the day of the examination : Partial Pressure of O2, PaCO2 (partial pressure) and hematocrit * To collect possible additional examinations : brain scan, EEG. These are non-invasive exams that do not require patient displacement. Only the samples taken by the medical team as part of the treatment will be analyzed.

Also known as: Examination that involves a TCD and an TTE
Patient treated with ECMO

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult patient who receiving ECMO therapy

You may not qualify if:

  • cervico-encephalic vasculopathy
  • lacked an acoustic window allowing for adequate TCD examination
  • stroke in medical past.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Toulouse

Toulouse, 31059, France

RECRUITING

Study Officials

  • Fanny BOUNES, MD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Isabelle OLIVIER, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Patient treated with Venoarterial Extracorporeal membrane oxygenation (ECMO) Realization of transcranial doppler (TCD) of the right and left middle cerebral artery in the first 48 hours of the setting up of the ECMO with joint realization of an Trans-thoracic echocardiography (TTE) then every 24 hours until the end of the using of the ECMO and the realization of TCD and TTE during the 24 hours after removal of the ECMO.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2018

First Posted

March 7, 2018

Study Start

April 5, 2018

Primary Completion

September 1, 2020

Study Completion

September 1, 2020

Last Updated

April 18, 2018

Record last verified: 2018-04

Locations